首頁 / ETF介紹 / 個別ETF-全部持股
Tema腫瘤學主動型ETF〈CANC〉
Tema腫瘤學主動型ETF(CANC)-全部持股
資料日期:2024/11/29
個股名稱投資比例(%)持有股數
REGENERON PHARMACEUTICALS,INC.5.453,515
GILEAD SCIENCES,INC.5.4328,632
ASTRAZENECA PLC5.1718,859
REVOLUTION MEDICINES,INC.4.6338,518
BLUEPRINT MEDICINES CORP.4.2921,957
INCYTE CORP.4.2927,709
ARGENX SE4.273,385
ILLUMINA,INC.3.8512,998
CHUGAI PHARMACEUTICAL CO.,LTD.3.3237,136
DAIICHI SANKYO CO.,LTD.3.0347,960
EXELIXIS,INC.2.9740,192
MERCK & CO.,INC.2.9113,741
AGIOS PHARMACEUTICALS,INC.2.8323,474
CRISPR THERAPEUTICS AG2.4623,591
BEIGENE LTD.2.425,705
SPRINGWORKS THERAPEUTICS,INC.2.4128,108
GUARDANT HEALTH,INC.2.3732,941
MEREO BIOPHARMA GROUP PLC2.33319,013
NUVALENT,INC.2.1110,597
GENMAB A/S2.1048,420
NOVARTIS AG2.029,360
DAY ONE BIOPHARMACEUTICALS,INC.1.8063,787
EXACT SCIENCES CORP.1.7413,699
ARCELLX,INC.1.618,805
INTELLIA THERAPEUTICS,INC.1.5750,281
SCHRODINGER,INC.1.5434,005
CELLDEX THERAPEUTICS,INC.1.5426,896
AMGEN,INC.1.412,444
LANTHEUS HOLDINGS,INC.1.357,265
LEGEND BIOTECH CORP.1.2313,847
MERUS NV1.2213,216
SIEMENS HEALTHINEERS AG1.2010,835
BIONTECH SE1.024,109
JANUX THERAPEUTICS,INC.0.949,818
COGENT BIOSCIENCES,INC.0.9347,353
NURIX THERAPEUTICS,INC.0.9020,585
CASH & CASH EQUIVALENTS0.89N/A
ORIC PHARMACEUTICALS,INC.0.8541,481
IDEAYA BIOSCIENCES,INC.0.8114,655
MODERNA,INC.0.778,642
BICYCLE THERAPEUTICS PLC0.7517,854
CULLINAN THERAPEUTICS,INC.0.7025,934
IMMUNOCORE HOLDINGS PLC0.6910,208
ARCUS BIOSCIENCES,INC.0.6620,278
RELAY THERAPEUTICS,INC.0.5858,960
TERNS PHARMACEUTICALS,INC.0.5743,947
JASPER THERAPEUTICS,INC.0.5411,347
CG ONCOLOGY,INC.0.537,598
CORBUS PHARMACEUTICALS HOLDINGS,INC.0.5314,605
ARVINAS,INC.0.488,911
相關基金
相關ETF

附註:
一、 績效計算為原幣別報酬,且皆有考慮配息情況。基金配息率不代表基金報酬率,且過去配息率不代表未來配息率。所有基金績效,均為過去績效,不代表未來之績效表現,亦不保證基金之最低投資收益。
二、 基金淨值可能因市場因素而上下波動,基金淨值僅供參考,實際以基金公司公告之淨值為準;海外市場指數類型基金,以交易日當天收盤價為淨值參考價。
三、 上述銷售費用僅供參考,實際費率以各銷售機構為主。
四、 上述資料只供參考用途,嘉實資訊自當盡力提供正確訊息,但如有錯漏或疏忽,本公司或關係企業與其任何董事或任何受僱人,恕不負任何法律責任。
最近查閱的商品
有興趣此檔ETF的網友也看過下列ETF